Skip to main content

Latest Articles

Latest Articles

Showing 9 / 1250 Weight Loss articles

Study: GLP-1s Reduce Addiction Risks Beyond Weight Loss
GLP-1 Medications

Study: GLP-1s Reduce Addiction Risks Beyond Weight Loss

A groundbreaking study in the British Medical Journal reveals that GLP-1 drugs like Ozempic offer benefits far beyond weight loss and diabetes control—they significantly reduce risks of alcohol, tobacco, cannabis, and cocaine abuse. Among 606,434 US veterans with type 2 diabetes, these medications lowered substance abuse risks by up to 20%. Experts caution that while promising, more research is needed.

Shotlee··5 min read
Ireland's Each-Way Bet on Wegovy and Mounjaro Rivals
Pharmaceutical Industry

Ireland's Each-Way Bet on Wegovy and Mounjaro Rivals

A spectacular backfire in Novo Nordisk's head-to-head trial against Eli Lilly's Mounjaro has widened the gap in the weight loss drug race, yet Ireland stands to gain from both giants. With billions in investments, thousands of jobs, and massive tax revenues, the Republic is placing an each-way bet on Wegovy and Mounjaro. This economic tie underscores pharma's pivotal role in Ireland's prosperity.

Shotlee··6 min read